Immunosuppression Therapy

Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs.

Year introduced: 2022 (1971)

PubMed search builder options

Subheadings:

Restrict to MeSH Major Topic.

Do not include MeSH terms found below this term in the MeSH hierarchy.

Tree Number(s): E02.095.465.425.450, E05.478.610

MeSH Unique ID: D007165

Entry Terms:

• Immunosuppression Therapies
• Therapies, Immunosuppression
• Therapy, Immunosuppression
• Antirejection Therapy
• Anti-Rejection Therapy
• Anti-Rejection Therapies
• Anti Rejection Therapy
• Immunosuppressive Therapy
• Immunosuppressive Therapies
• Therapies, Immunosuppressive
• Therapy, Immunosuppressive
• Immunosuppression
• Immunosuppressions
• Therapy, Antirejection
• Antirejection Therapies
• Therapy, Anti-Rejection

Previous Indexing:

• Antilymphocyte Serum (1968-1970)
• Immune Tolerance (1966-1970)
• Immunity (1966-1970)
• Immunosuppressive Agents (1966-1970)

See Also:

• Antilymphocyte Serum
• Immune Tolerance
• Immunocompromised Host

All MeSH Categories
Analytical, Diagnostic and Therapeutic Techniques and Equipment Category
Therapeutics
Biological Therapy
Immunomodulation
Immunotherapy
Immunosuppression Therapy
Desensitization, Immunologic
Sublingual Immunotherapy
Graft Enhancement, Immunologic
Lymphocyte Depletion
Transplantation Conditioning

All MeSH Categories
Analytical, Diagnostic and Therapeutic Techniques and Equipment Category
Investigative Techniques
Immunologic Techniques
Immunosuppression Therapy
Desensitization, Immunologic
Sublingual Immunotherapy
Graft Enhancement, Immunologic
Lymphocyte Depletion
Transplantation Conditioning